Filter
1195
Text search:
CD4
Featured
124
359
Language
Document type
712
227
114
47
36
29
18
3
3
2
2
Countries
85
46
38
34
33
28
24
24
21
21
21
18
18
18
17
17
15
14
14
14
14
13
13
13
12
12
11
11
10
10
10
9
9
9
9
9
8
8
8
8
7
6
6
6
6
6
6
5
5
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
642
121
41
38
25
13
11
Toolboxes
211
174
86
35
17
14
11
11
11
9
7
6
6
5
3
3
3
2
2
2
2
2
1
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th
...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b
...
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
COVID - 19 and PREGNANCY
Management guidelines for SARS-CoV-2 infection
Strengthening of vaccination interventions during and post-Health Emergency by SARS-CoV-2
General Objective
To strengthen vaccination interventions in the territory, during the COVID-19 health emergency, in order to emergency due to COVID-19, in order to prevent the reintroduction and maintain co
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
orientations provisoires, première publication le 25 janvier 2021, mise à jour le 15 juin 2021, mise à jour le 19 novembre 2021
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Guidelines for the diagnosis and treatment of COVID-19 in intensive care units
Active Community Policy Strategy - Containment, mitigation and recovery plan on post-confinement in response to COVID-19
These guidelines have been prepared by the Sub directorate: Maternal Health for the guidance of health workers (doctors and midwives) providing obstetric, surgical and anaesthetic services for pregnant women in district clinics, health centres and district hospitals. These guidelines are intended fo
...
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
Nursing Care Protocol for adult patients with COVID-19 without respiratory complications
Guidance for Orphans and Vulnerable Children Programs
Vaccinator's Manual. MODERNA Vaccine
